Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs long rifampicin + levofloxacin regimens for early postoperative or hematogenous staphylococcal prosthetic joint infection
2007-001863-31Phase 4Terminated
- Sponsor
- Bellvitge University Hospital
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rifampicin and levofloxacin in periprosthetic joint infection (PJI) and Staphylococcal periprosthetic joint infection (SPJI) (2 arms), sponsored by Bellvitge University Hospital. Primary endpoint: Response evaluation criteria. Started Oct 2008; status: terminated.
02
Drugs
rifampicinlevofloxacin
03
Conditions
periprosthetic joint infection (PJI)Staphylococcal periprosthetic joint infection (SPJI)
Beyond the preview
Go deeper on 2007-001863-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001863-31.